Publication | Open Access

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study

Gastrointestinal OncologyOral CapecitabineMedicinePharmacologyColorectal CancerPharmacotherapyBiweekly OxaliplatinCancer TreatmentOxxel RegimenOncologyRadiation Oncology